Education
About Us
Working with TipRanks
Follow Us
Privia Health Group (PRVA)
NASDAQ:PRVA
PRVA Analyst Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PRVA Stock 12 Month Forecast
Average Price Target
$29.35
▲(41.72% Upside)
| Highest Price Target$35.00 | Average Price Target$29.35 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$21.5→$22.5
Buy
8.64%
Upside
Upgraded
08/12/25
Truist Financial
$30
Buy
44.86%
Upside
Reiterated
08/12/25
Piper Sandler
$35
Buy
69.00%
Upside
Reiterated
08/11/25
Barclays
$24→$21
Hold
1.40%
Upside
Reiterated
08/10/25
Canaccord Genuity
$32
Buy
54.51%
Upside
Reiterated
08/07/25
Privia Health Group: Strong Performance and Promising Outlook Justify Buy RatingPre-market trading was delivering the bounce we anticipated, a 2Q beat that extended Privia's track record of delivering upside. However, shares cooled off after the initial positive reaction. Notably, Privia spent the initial part of the conference call Q&A highlighting the company's differentiation in the physician enablement and value-based care segments. You can sense a level of frustration that the company's success in delivering consistent growth and improving profitability and FCF generation is not fully appreciated. They have said it many times that they are in this for the long haul and all the blocking and tackling will eventually prove successful. At its core, Privia is an operating platform enabling physician groups to grow their business, both fee- for-service and value-based care, and to do so profitably.
William Blair
―
Buy
―
Reiterated
08/07/25
Leerink Partners
$33
Buy
59.34%
Upside
Reiterated
08/07/25
Needham
$30
Buy
44.86%
Upside
Reiterated
08/07/25
Evercore ISI
$30→$28
Buy
35.20%
Upside
Reiterated
08/07/25
TD Cowen
$30
Buy
44.86%
Upside
Reiterated
08/07/25
J.P. Morgan
$29→$32
Buy
54.51%
Upside
Reiterated
05/28/25
Citizens JMP
$29
Buy
40.03%
Upside
Reiterated
04/28/25
Robert W. Baird
$24→$26
Buy
25.54%
Upside
Reiterated
04/15/25
Stephens
$26→$30
Buy
44.86%
Upside
Reiterated
03/05/25
BTIG
$35
Buy
69.00%
Upside
Reiterated
03/05/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$21.5→$22.5
Buy
8.64%
Upside
Upgraded
08/12/25
Truist Financial
$30
Buy
44.86%
Upside
Reiterated
08/12/25
Piper Sandler
$35
Buy
69.00%
Upside
Reiterated
08/11/25
Barclays
$24→$21
Hold
1.40%
Upside
Reiterated
08/10/25
Canaccord Genuity
$32
Buy
54.51%
Upside
Reiterated
08/07/25
Privia Health Group: Strong Performance and Promising Outlook Justify Buy RatingPre-market trading was delivering the bounce we anticipated, a 2Q beat that extended Privia's track record of delivering upside. However, shares cooled off after the initial positive reaction. Notably, Privia spent the initial part of the conference call Q&A highlighting the company's differentiation in the physician enablement and value-based care segments. You can sense a level of frustration that the company's success in delivering consistent growth and improving profitability and FCF generation is not fully appreciated. They have said it many times that they are in this for the long haul and all the blocking and tackling will eventually prove successful. At its core, Privia is an operating platform enabling physician groups to grow their business, both fee- for-service and value-based care, and to do so profitably.
William Blair
―
Buy
―
Reiterated
08/07/25
Leerink Partners
$33
Buy
59.34%
Upside
Reiterated
08/07/25
Needham
$30
Buy
44.86%
Upside
Reiterated
08/07/25
Evercore ISI
$30→$28
Buy
35.20%
Upside
Reiterated
08/07/25
TD Cowen
$30
Buy
44.86%
Upside
Reiterated
08/07/25
J.P. Morgan
$29→$32
Buy
54.51%
Upside
Reiterated
05/28/25
Citizens JMP
$29
Buy
40.03%
Upside
Reiterated
04/28/25
Robert W. Baird
$24→$26
Buy
25.54%
Upside
Reiterated
04/15/25
Stephens
$26→$30
Buy
44.86%
Upside
Reiterated
03/05/25
BTIG
$35
Buy
69.00%
Upside
Reiterated
03/05/25
Best Analysts Covering Privia Health Group
1 Month
xxx
Success Rate
4/10 ratings generated profit
Average Return
+1.10%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of +1.10% per trade.
3 Months
xxx
Success Rate
5/10 ratings generated profit
Average Return
+0.48%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.48% per trade.
1 Year
Success Rate
5/8 ratings generated profit
Average Return
+5.04%
reiterated a buy rating 4 months ago
Copying Constantine Davides's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +5.04% per trade.
2 Years
xxx
Success Rate
3/8 ratings generated profit
Average Return
-2.14%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -2.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PRVA Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
1
0
0
0
5
Buy
26
24
19
15
9
Hold
1
3
3
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
27
22
17
14
Each month's total comprises the sum of three months' worth of ratings.
PRVA Financial Forecast
PRVA Stock Forecast FAQ
What is PRVA’s average 12-month price target, according to analysts?
Based on analyst ratings, Privia Health Group’s 12-month average price target is 29.35.
What is PRVA’s upside potential, based on the analysts’ average price target?
Privia Health Group has 41.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PRVA a Buy, Sell or Hold?
Privia Health Group has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
What is Privia Health Group’s price target?
The average price target for Privia Health Group is 29.35. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $21.00. The average price target represents 41.72% Increase from the current price of $20.71.
The highest analyst price target is $35.00 ,the lowest forecast is $21.00. The average price target represents 41.72% Increase from the current price of $20.71.
What do analysts say about Privia Health Group?
Privia Health Group’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of PRVA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.